年初以来 ,哈药集团有限公司在营销工作中以突出集团整体竞争能力为重点 ,以不断提高市场的占有率作为市场营销工作的主攻目标。在继续巩固提高 1 1个销售收入超亿元战略品种市场占有率的基础上 ,重点抓好头孢拉定、益萨林、铃兰欣、头孢他定、司乐平、脑安片、世一治感佳、安 Since the beginning of the year, Harbin Pharmaceutical Group Co., Ltd. has focused on highlighting the overall competitiveness of the Group in its marketing work, and has continuously increased the market share as the main target of marketing work. Continuing to consolidate and increase the market share of more than one hundred million yuan in strategic varieties with a sales revenue of over 100 million yuan, we will focus on Cephradine, Yisalin, Lilan Lan, Ceftazidime, Si Leping, Naoan Tablets and Shiyi Yizhi. An